QT Imaging CEO presents Shiftmaker Award to Martina Navratilova

2 min read     Updated on 29 Jun 2026, 08:41 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

QT Imaging Holdings, Inc. CEO Dr. Raluca Dinu presented the Shiftmaker Award to Martina Navratilova in London on June 27, recognizing her advocacy in women's health. The company participated in panels during Wimbledon week, discussing advancements in breast health and personalized care. Key topics included breast density awareness and improving patient experiences.

powered bylight_fuzz_icon
44291489

*this image is generated using AI for illustrative purposes only.

QT Imaging Holdings, Inc. CEO Dr. Raluca Dinu presented the Shiftmaker Award to tennis champion Martina Navratilova during a ceremony in London on June 27. The event, part of the Sports Shiftmaker Awards, recognized Navratilova for her achievements in sports and her advocacy for breast health awareness and early detection. QT Imaging served as the presenting partner for the award, underscoring its commitment to advancing women's health through innovative imaging technologies.

The ceremony and subsequent panels were hosted by The Shift, a women's media platform backed by Harvard University and Gloria Steinem. The events brought together leaders from healthcare, investment, and advocacy to discuss the future of women's health. Dr. Dinu emphasized the growing alignment among patients, clinicians, and investors around the need for personalized, patient-centered healthcare solutions.

Following the award ceremony, Dr. Dinu joined Navratilova, biotech investor Kriti Lall of Perceptive Advisors, and journalist Sophia Li for a panel titled "The Paradigm Shift: Redefining the Standard of Care in Women’s Health." The discussion explored how advances in breast health and early detection are transforming outcomes for women. Panelists highlighted the importance of empowering women with information and access to innovative care.

On the same day, Dr. Dinu participated in another panel, "The Era of the Execution Shift for Women’s Health: Scaling Science and Access in Women’s Health." The session focused on innovation in breast cancer and included Susan Wang of T. Rowe Price, Caroline Jefferies of the Center for Research in Women’s Health, and Jaya Rosenmeir of Novartis. The panel was moderated by a journalist from ELLE UK.

Throughout the forums, discussions centered on the convergence of patient advocacy, technological innovation, and investment capital driving progress in women's health. Key topics included breast density awareness, personalized screening approaches, and improving the patient experience. QT Imaging’s participation aligned with its mission to shape the future of breast health through technologies that support more personalized care.

Key Participants and Events

Event Date Participants
Shiftmaker Award Ceremony June 27 Dr. Raluca Dinu, Martina Navratilova
"The Paradigm Shift" Panel June 27 Dr. Raluca Dinu, Martina Navratilova, Kriti Lall, Sophia Li
"The Era of the Execution Shift" Panel June 27 Dr. Raluca Dinu, Susan Wang, Caroline Jefferies, Jaya Rosenmeir

Navratilova, a 59-time Grand Slam titleholder and two-time cancer survivor, was honored for her resilience and advocacy. Her story, Dr. Dinu noted, embodies the themes driving progress in women's health today. The events highlighted the increasing focus on breast health and the need for safe, accessible, and patient-centered imaging technologies.

How will QT Imaging leverage its partnership with high-profile advocates like Navratilova to accelerate regulatory approval or insurance reimbursement for its technologies?

What specific investment trends or funding gaps were identified during the panels regarding the scalability of women's health startups?

How might the increasing focus on personalized screening and breast density awareness influence future FDA guidelines for breast imaging devices?

like15
dislike